BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 18651664)

  • 1. Histone deacetylases 1 and 2 are expressed at distinct stages of neuro-glial development.
    MacDonald JL; Roskams AJ
    Dev Dyn; 2008 Aug; 237(8):2256-67. PubMed ID: 18651664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation.
    Brunmeir R; Lagger S; Seiser C
    Int J Dev Biol; 2009; 53(2-3):275-89. PubMed ID: 19412887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative and positive regulation of gene expression by mouse histone deacetylase 1.
    Zupkovitz G; Tischler J; Posch M; Sadzak I; Ramsauer K; Egger G; Grausenburger R; Schweifer N; Chiocca S; Decker T; Seiser C
    Mol Cell Biol; 2006 Nov; 26(21):7913-28. PubMed ID: 16940178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective regulation of class I and class II histone deacetylases expression by inhibitors of histone deacetylases in cultured mouse neural cells.
    Ajamian F; Salminen A; Reeben M
    Neurosci Lett; 2004 Jul; 365(1):64-8. PubMed ID: 15234474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and function of histone deacetylases in rheumatoid arthritis synovial fibroblasts.
    Horiuchi M; Morinobu A; Chin T; Sakai Y; Kurosaka M; Kumagai S
    J Rheumatol; 2009 Aug; 36(8):1580-9. PubMed ID: 19531758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage-specific induction of DNA methyltransferases in olfactory receptor neuron development.
    MacDonald JL; Gin CS; Roskams AJ
    Dev Biol; 2005 Dec; 288(2):461-73. PubMed ID: 16288735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1.
    Huang BH; Laban M; Leung CH; Lee L; Lee CK; Salto-Tellez M; Raju GC; Hooi SC
    Cell Death Differ; 2005 Apr; 12(4):395-404. PubMed ID: 15665816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase 2 modulates p53 transcriptional activities through regulation of p53-DNA binding activity.
    Harms KL; Chen X
    Cancer Res; 2007 Apr; 67(7):3145-52. PubMed ID: 17409421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inactivating mutation in HDAC2 leads to dysregulation of apoptosis mediated by APAF1.
    Hanigan CL; Van Engeland M; De Bruine AP; Wouters KA; Weijenberg MP; Eshleman JR; Herman JG
    Gastroenterology; 2008 Nov; 135(5):1654-1664.e2. PubMed ID: 18834886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.
    Lin YC; Lin JH; Chou CW; Chang YF; Yeh SH; Chen CC
    Cancer Res; 2008 Apr; 68(7):2375-83. PubMed ID: 18381445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of histone deacetylases (HDAC) expression in human prostate cancer reveals distinct class I HDAC profiles between epithelial and stromal cells.
    Waltregny D; North B; Van Mellaert F; de Leval J; Verdin E; Castronovo V
    Eur J Histochem; 2004; 48(3):273-90. PubMed ID: 15590418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and functional characterization of recombinant human HDAC1 and HDAC3.
    Li J; Staver MJ; Curtin ML; Holms JH; Frey RR; Edalji R; Smith R; Michaelides MR; Davidsen SK; Glaser KB
    Life Sci; 2004 Apr; 74(22):2693-705. PubMed ID: 15043985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.
    Weichert W; Röske A; Niesporek S; Noske A; Buckendahl AC; Dietel M; Gekeler V; Boehm M; Beckers T; Denkert C
    Clin Cancer Res; 2008 Mar; 14(6):1669-77. PubMed ID: 18347167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase interacts directly with DNA topoisomerase II.
    Tsai SC; Valkov N; Yang WM; Gump J; Sullivan D; Seto E
    Nat Genet; 2000 Nov; 26(3):349-53. PubMed ID: 11062478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming pathways unleashed by a HDAC2 mutation in human cancer.
    Ropero S; Ballestar E; Alaminos M; Arango D; Schwartz S; Esteller M
    Oncogene; 2008 Jun; 27(28):4008-12. PubMed ID: 18264134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
    Sekhavat A; Sun JM; Davie JR
    Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of histone deacetylase 2 is found in human gastric cancer.
    Song J; Noh JH; Lee JH; Eun JW; Ahn YM; Kim SY; Lee SH; Park WS; Yoo NJ; Lee JY; Nam SW
    APMIS; 2005 Apr; 113(4):264-8. PubMed ID: 15865607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2).
    Methot JL; Chakravarty PK; Chenard M; Close J; Cruz JC; Dahlberg WK; Fleming J; Hamblett CL; Hamill JE; Harrington P; Harsch A; Heidebrecht R; Hughes B; Jung J; Kenific CM; Kral AM; Meinke PT; Middleton RE; Ozerova N; Sloman DL; Stanton MG; Szewczak AA; Tyagarajan S; Witter DJ; Secrist JP; Miller TA
    Bioorg Med Chem Lett; 2008 Feb; 18(3):973-8. PubMed ID: 18182289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase 1 is required for cell cycle exit and differentiation in the zebrafish retina.
    Stadler JA; Shkumatava A; Norton WH; Rau MJ; Geisler R; Fischer S; Neumann CJ
    Dev Dyn; 2005 Jul; 233(3):883-9. PubMed ID: 15895391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of histone deacetylase activities.
    Sengupta N; Seto E
    J Cell Biochem; 2004 Sep; 93(1):57-67. PubMed ID: 15352162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.